Cargando…
Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population
OBJECTIVES: Autoantibodies against apolipoprotein A1 (anti‐apoA1 IgGs) and its C‐terminal region (cter apoA1) have emerged as an independent biomarker for cardiovascular disease. Cter apoA1 mimetic peptides were shown to reverse the deleterious anti‐apoA1 IgG effects in vitro. We evaluated the assoc...
Autores principales: | Vuilleumier, Nicolas, Antiochos, Panagiotis, Marques‐Vidal, Pedro, Pagano, Sabrina, Virzi, Julien, Satta, Nathalie, Hartley, Oliver, Gaertner, Hubert, Brandt, Karim J, Burger, Fabienne, Montecucco, Fabrizio, Waeber, Gerard, Mach, François, Vollenweider, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734471/ https://www.ncbi.nlm.nih.gov/pubmed/33343896 http://dx.doi.org/10.1002/cti2.1220 |
Ejemplares similares
-
Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms
por: Antiochos, Panagiotis, et al.
Publicado: (2017) -
The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?
por: Pagano, Sabrina, et al.
Publicado: (2015) -
Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques
por: da Silva, Rafaela F., et al.
Publicado: (2020) -
Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases
por: Teixeira, Priscila Camillo, et al.
Publicado: (2014) -
Association of activity behaviours and patterns with cardiovascular risk factors in Swiss middle-aged adults: The CoLaus study
por: Gubelmann, Cédric, et al.
Publicado: (2018)